Vident Advisory, LLC 10x Genomics, Inc. Transaction History

Vident Advisory, LLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 14, 2024	BUY	$19.45 - $37.37 $81,125 - $155,870	4,171 Added 53.28%	11,999 $233 Million
Q1 2024 May 14, 2024	BUY	$36.08 - $54.3 $28,791 - $43,331	798 Added 11.35%	7,828 $294 Million
Q4 2023 Feb 14, 2024	SELL	$34.32 - $57.55 $4,015 - $6,733	-117 Reduced 1.64%	7,030 $393 Million
Q3 2023 Feb 21, 2024	BUY	$40.86 - $62.98 $4,780 - $7,368	117 Added 1.66%	7,147 $295 Million
Q3 2023 Nov 14, 2023	BUY	$40.86 - $62.98 $292,026 - $450,118	7,147 New	7,147 $295 Million

291

94.7M

263K

85.1K

Ticker TXG
Exchange NASDAQ
Sector Healthcare
Industry Health Information Services
Shares Outstandng 95,046,400
Market Cap $1.5B
Description
10x Genomics, Inc., a life science technology company, develops and sells instruments, consumables, and software for analyzing biological systems in North America, Europe, the Middle East, Africa, China, and the Asia Pacific. The company provides chromium and chromium connect instruments, microfluidic chips, slides, reagents, and other consumabl...

Get notified when there are updates to the investment portfolio of Vident Advisory, LLC, based on Form 13F filings with the SEC.

Stay updated on Vident Advisory, LLC with notifications on news.